SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (13653)1/23/1998 9:58:00 AM
From: Henry Niman  Read Replies (1) | Respond to of 32384
 
TD, The NDA was slated for 4Q, so there would have been no sales until 1999. However, I suspect that LGND was slated to get a milestone payment for the NDA filing, but it may not have been big, since the alliance was created to develop an osteoporosis drug (and two of LGND's selections for PFE are in the clinic for that indication).



To: Arthur Radley who wrote (13653)1/23/1998 10:00:00 AM
From: Andrew H  Respond to of 32384
 
>>Wasn't the NDA projected in time to impact potential sales for this year?<<

NDA was for Q4 of 98, so there would have been no sales for at least 6 months and possibly 12 or more. The only impact would be a rather small milestone payment which may be covered by progressing with the osteo indication and the other LGND compound.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News